Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
NCT00463775
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Recruitment not progressing as planned.
Conditions
Alcohol Dependence
Borderline Personality Disorder
Interventions
DRUG:
Topiramate
Sponsor
Elizabeth Ralevski